Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression

Triple negative breast cancer (TNBC) is non-responsive to conventional anti-hormonal and Her2-targeted therapies, making it necessary to identify new molecular targets for therapy. Long non-coding RNA anti-differentiation ncRNA (lncRNA DANCR) was identified participating in carcinogenesis of hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Sha, Yuan, Dongya, Liu, Yuejun, Han, Baosan, Zhong, Nanbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612229/
https://www.ncbi.nlm.nih.gov/pubmed/28760736
http://dx.doi.org/10.1242/bio.023135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612229/
https://www.ncbi.nlm.nih.gov/pubmed/28760736
http://dx.doi.org/10.1242/bio.023135

Ejemplares similares